ANITA SCHEIMAN: Open Payments
NPI 1265073217 · POWELL, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,081 in 147 payments from 17 companies in 2025. Trend: 2023 $941 · 2024 $2,274 · 2025 $6,081
Speaker / faculty: $2,565Food & beverage: $2,560Travel & lodging: $946Education: $10
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 20 | $4,297 |
| ABBVIE INC. | 43 | $608 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 22 | $250 |
| Janssen Biotech, Inc. | 14 | $211 |
| Phathom Pharmaceuticals, Inc. | 20 | $146 |
| Regeneron Healthcare Solutions, Inc. | 4 | $100 |
| Gilead Sciences, Inc. | 4 | $93 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| GENZYME CORPORATION | 3 | $58 |
| Ardelyx, Inc. | 3 | $47 |
Products named: REZDIFFRA, XIFAXAN, TREMFYA, CREON, DUPIXENT, VOQUEZNA, RINVOQ, MAVYRET.
Industry payments across TN — which companies pay providers there.
